3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Myeloproliferative Disorders
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Graft vs Host Disease
1
Interventions
Cyclophosphamide
69
fludarabine phosphate
66
Peripheral Blood Stem Cell Transplantation
52
Mycophenolic Acid
48
Whole-Body Irradiation
47
Tacrolimus
44
Busulfan
43
Cyclosporine
38
Azacitidine
35
Methotrexate
28
Filgrastim
27
Antilymphocyte Serum
27
Cytarabine
26
Decitabine
23
Melphalan
22
Radiotherapy
21
fludarabine
20
venetoclax
16
Methylprednisolone
16
Cyclosporins
13
Cord Blood Stem Cell Transplantation
13
Injections
12
Granulocyte Colony-Stimulating Factor
12
Flow Cytometry
12
Specimen Handling
11
Etoposide
11
Biopsy
11
Stem Cell Transplantation
10
Sirolimus
10
Clofarabine
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Myelomonocytic, Chronic
×
Calcineurin Inhibitors
×
Clear all
NCT01749111
2017-03-03
CICLODECH
Hospital Israelita Albert Einstein
Phase 3
Terminated
3 enrolled